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Intrinsic resistance to drugs is one of the main determining factors in bacterial survival in the
intestinal ecosystem. This is mediated by, among others, multidrug resistance (MDR) transporters,
membrane proteins which extrude noxious compounds with very different chemical structures and
cellular targets. Two genes from Bifidobacterium breve encoding hypothetical membrane
proteins with a high homology with members of the ATP-binding cassette (ABC) family of multidrug
efflux transporters, were expressed separately and jointly in Lactococcus lactis. Cells co-expressing
both proteins exhibited enhanced resistance levels to the antimicrobials nisin and polymyxin B.
Furthermore, the drug extrusion activity in membrane vesicles was increased when both proteins
were co-expressed, compared to membranes in which the proteins were produced independently.
Both proteins were co-purified from the membrane as a stable complex in a 1 : 1 ratio. This is
believed to be the first study of a functional ABC-type multidrug transporter in Bifidobacterium and
contributes to our understanding of the molecular mechanisms underlying the capacity of intestinal
bacteria to tolerate cytotoxic compounds.
INTRODUCTION
Bifidobacteria are important members of the human gut
microbiota, in which they can be present at concentrations
as high as 1011 cells per g faeces, representing up to 91% of
the total microbial population in breast-fed infants
(Harmsen et al., 2000). Their presence has been associated
with beneficial effects. On the basis of their role in
promoting human wellbeing, some species and strains of
the genus Bifidobacterium are considered to be probiotic and
are used as active ingredients in functional foods, mainly
dairy-based products (Ouwehand et al., 2002). Well-
documented clinically established applications of some
strains of this genus are the treatment of diarrhoea and the
balancing of the intestinal microbiota (Salminen &
Gueimonde, 2004), while other health-promoting actions,
such as anticarcinogenic activity, immunomodulation and
reduction of serum cholesterol levels, have been suggested
(Isolauri et al., 2004). Bifidobacterium breve, one of the
representative species of its genus, is among the predomi-
nant bacteria present in the gastrointestinal tract of infants
(Matsuki et al., 1999).
Enteric bacteria have evolved to tolerate inhibitory factors in
the intestinal niche. Their survival depends on tolerance to
host-produced substances, such as bile (Begley et al., 2005;
Yokota et al., 2000), and antimicrobial peptides (Ganzle et
al., 1999; Mahida et al., 1997), but they are also conditioned
by exposure to exogenous cytotoxic agents, including
antibiotics (Vedantam & Hecht, 2003). Nowadays, drug
efflux, mediated by MultiDrug Resistance (MDR) trans-
porters, is considered as one of the main mechanisms
responsible for these resistances (Grkovic et al., 2002). These
proteins can be subdivided into two groups according to
structural and bioenergetic criteria. ATP-binding cassette
(ABC) transporters power the transport via the hydrolysis of
ATP, whereas the activity of secondary transporters is
dependent on the transmembrane electrochemical gradient,
typically the proton-motive force (Kim et al., 2004;
Mazurkiewicz et al., 2005). Most of the bacterial multidrug
efflux systems characterized up to now belong to the second
class of transporters (Putman et al., 2000), and just a few of
them, such as LmrA and LmrCD from Lactococcus lactis
(Lubelski et al., 2004; van Veen et al., 1996), HorA from
Abbreviations: ABC, ATP-binding cassette; AMP-PNP, 59-(b,c-imido)
triphosphate; Bbm, Bifidobacterium breve multidrug transporter; DDM,
n-dodecyl b-D-maltoside; MDR, multidrug resistance.
The GenBank/EMBL/DDBJ accession number for the sequence of the
B. breve gene cluster is DQ486860.
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Lactobacillus brevis (Sakamoto et al., 2001), MsbA from
Escherichia coli (Karow & Georgopoulus, 1993), BmrA
from Bacillus subtilis (Orelle et al., 2003) and EfrAB from
Enterococcus faecalis (Lee et al., 2003), belong to the ABC-
type family.
Recent evidence indicated that B. breve is more resistant to
antibiotics than other Bifidobacterium species (Moubareck
et al., 2005), suggesting that this species could have a
stronger intrinsic resistance. In a previous study, we
characterized BbmR, a membrane protein from B. breve
which was able to confer resistance to macrolides and
exhibited characteristics reminiscent of MDR proteins
(Margolles et al., 2005). Its homologue in Bifidobacterium
longum, named Ctr, was also found to confer resistance to
several antibiotics and to transport radioactive cholate
(Price et al., 2006). The current study presents work relating
to B. breve genes that play a role in its intrinsic resistance to
cytotoxic compounds. We describe the gene cloning and
functional characterization of a novel bifidobacterial ABC-
type multidrug transporter in L. lactis, which shares both
structural and functional properties with prokaryotic and
eukaryotic MDR proteins, being able to confer resistance to
several antimicrobials and to transport cytotoxic drugs.
METHODS
Chemicals. DNase A, creatine phosphokinase, phosphocreatine,
potassium EDTA, DTT, HEPES, adenosine 59-(b,c-imido) triphosphate
(AMP-PNP), chloramphenicol, erythromycin, nisin, polymyxin B,
imidazole and n-dodecyl b-D-maltoside (DDM) were purchased
from Sigma. Takara supplied all restriction enzymes, excluding
BspLU11I (Roche Applied Science). Platinum-Pfx DNA polymerase
and Hoechst-33342 [29-(4-ethoxyphenyl)-5-(4-methyl-1-piperazi-
nyl)-2,59-bi-1H-benzimidazole] were obtained from Invitrogen, and
Ni2+ nitriloacetic acid (Ni-NTA) agarose was supplied by Qiagen.
E-test strips were from AB Biodisk and ATP was from Amersham
Biosciences. All chemicals were reagent grade and all solutions were
made with molecular biology reagent water (Sigma).
Bacterial strains, plasmids, and culture conditions. Bacteria
and plasmids used in this study are shown in Table 1. Bifi-
dobacterium breve UCC2003 was grown at 37 uC in MRS medium
(Merck) supplemented with 0?05% (w/v) L-cysteine in an anaerobic
chamber (Mac500, Don Whitley Scientific). Lactococcus lactis subsp.
lactis NZ9000 and NZ9700 (Kuipers et al., 1993, 1998) were culti-
vated at 30 uC in M17 broth (Oxoid) with 0?7% (w/v) glucose
(GM17) and 5 mg chloramphenicol or 5 mg erythromycin ml21
when they contained pNZ8048 and its derivatives or pNZE8048 and
its derivatives respectively. Cells cotransformed with pNAbcA (or
pNHAbcA) and pNAbcB were grown under the same conditions,
but in a medium that contained 3 mg chloramphenicol plus 3 mg
erythromycin ml21.
DNA and RNA manipulation, cloning of the genes, and
sequence analysis. DNA manipulations were carried out as
described by Sambrook et al. (1989). Total DNA was obtained from
B. breve as previously described (Margolles & de los Reyes-Gavila´n,
2003). Vector pNZE8048 was constructed by amplifying a DNA
fragment from the vector pNG8048 (Zu´n˜iga et al., 2002), with the
primers emr-f and emr-r (Table 1). The resulting PCR product was
Table 1. Bacterial strains, plasmids and primers
Strain or plasmid Relevant phenotype or genotype Source or reference
B. breve UCC2003 Infant isolate MacConaill et al. (2003)
L. lactis NZ9000 L. lactis MG1363 pepN : : nisRK Kuipers et al. (1998)
L. lactis NZ9700 Nisin-producing strain Kuipers et al. (1993)
pNZ8048 Gene expression vector, PnisA, Cm
r de Ruyter et al. (1996)
pNZE8048 Gene expression vector, PnisA, Em
r This work
pNAbcA pNZE8048 derivative; abcA This work
pNAbcB pNZ8048 derivative; abcB This work
pNHAbcA pNZE8048 derivative; His-tag abcA This work
Primer Sequence*
emr-f 59-AAGGCCAGGAAGATCTCCGATTCACAAAAAATAGGCACACG-39 This work
emr-r 59-CGATATCGGATCCGTCGACCCGTGC-39 This work
abcA-f 59-TGCGATCACATGTACGTCGATCCGGGAATCAATACCAGCGC-39 This work
abcA-r 59-ATACGGAGAATTCTTATTAAAACCCCTGTGCGGCGCC-39 This work
abcB-f 59-TGCGACCACCATGGCACAACGCAATACATTTCGCG-39 This work
abcB-r 59-GCCGACTCTAGATTACTACTCAGTAGCCCCGGTGG-39 This work
abcAh-f 59-GCTGTATCAAGATTCGCAAGCTGC-39 This work
abcAh-r 59-TGCGATCAGAATTCTTATTAGTGATGGTGATGGTGATGAAAC-
CCCTGTGCGGCG CCGGACTGG-39
This work
abcA-fq 59-ACGACTGGCAGCGATTCAAC-39 This work
abcA-rq 59-GACCTGCTCGACGATTGTGA-39 This work
abcB-fq 59-TTCTCCGACATCTTCACATTCTTC-39 This work
abcB-rq 59-CAGTACGAGGCTCCACAATGC-39 This work
*Restriction sites are underlined and the codons for the histidine tag are in bold italic.
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digested with SalI and BglII, and ligated with SalI/BglII-digested
pNZ8048, yielding pNZE8048, in which the chloramphenicol resis-
tance marker is replaced by an erythromycin resistance cassette.
The structural genes abcA and abcBwere amplified from the genome of
B. breve by PCR using primers abcA-f and abcA-r (for gene abcA), and
abcB-f and abcB-r (for gene abcB) (Table 1), respectively. Given that
the abcA gene contains an internal NcoI site, the enzyme BspLU11I,
which yields compatible ends with NcoI, was used in the cloning
procedure. The abcA gene was amplified, digested with BspLU11I and
EcoRI, and ligated into pNZE8048, previously treated with NcoI and
EcoRI, yielding pNAbcA. For abcB, the amplicon was digested with
NcoI and XbaI, and ligated with NcoI/XbaI-digested pNZ8048,
resulting in pNAbcB. Furthermore, in order to introduce a he-
xahistidine tag at the C-terminus of AbcA, a fragment of abcA was
amplified using the primers abcAh-f and abcAh-r (Table 1), digested
with ClaI and EcoRI, and ligated into pNAbcA, previously cut with the
same enzymes. This construction yielded plasmid pNHAbcA. The
vectors pNAbcA and pNAbcB were transformed into electrocompetent
L. lactis NZ9000 cells using previously described methods (de Ruyter
et al., 1996), and transformants were screened by restriction analysis of
the recovered plasmids. For co-expression of AbcA and AbcB, pNAbcA
(or pNHAbcA) was introduced into electrocompetent NZ9000 cells
containing pNAbcB. To confirm that no PCR-borne mutations were
introduced, the fidelity of the inserts was verified by DNA sequencing
of both strands with an ABI Prism 377 sequencer (Applied Biosystems).
Real-time PCR was used to assess the expression levels of abcA and
abcB. Primers abcA-fq, abcA-rq, abcB-fq and abcB-rq were chosen to
amplify internal fragments of 128 and 84 bp of abcA and abcB,
respectively (Table 1). Four independent cultures of L. lactis cells were
disrupted with glass beads (0?5 mm) in a FastPrep FP120 Instrument
(Thermo Savant). Total RNA was extracted using Tri-Reagent solution
according to the manufacturer’s instructions (Sigma). Two micro-
grams of total RNA was treated with 2 units of DNase (Fermentas) for
1 h at 37 uC. Then, cDNA was synthesized using the iScript cDNA
synthesis kit (Bio-Rad). Absence of chromosomal DNA contamination
was checked by real-time PCR. Real-time PCR reactions were carried
out using an ABI PRISM 7500 with a SYBR green PCR master mix
(Applied Biosystems). The efficiency was calculated based on the slope
of a standard curve. In all cases, the 16S rRNA level was used as an
internal control.
The stability of pNAbcA and pNAbcB co-existing in the same cell was
checked by growing the cells for more than 70 generations in GM17
broth containing chloramphenicol and erythromycin (five consecutive
cultures inoculated with 0?0037% (v/v) of a culture grown to an OD600
of about 1?2). In parallel, cells were plated on GM17 agar with and
without antibiotics, to confirm that all cells contained the two
antibiotic markers. Subsequently, 24 independent colonies (12 colonies
from plates inoculated with cultures grown for 42 generations, and 12
colonies from plates inoculated with cultures grown for 71 generations)
were analysed, and plasmids were extracted with the GenElute DNA kit
(Sigma) and digested with BglII to verify that no DNA recombination
had occurred. Furthermore, the genes abcA and abcB, and the upstream
region corresponding to the nisin promoter in pNAbcA and pNAbcB,
were sequenced after the five consecutive cultures to confirm that no
mutations were produced during growth under selective pressure when
both plasmids are present in the same cell.
DNA and protein sequences were analysed using the computer
program Clone Manager 5 (Scientific and Educational Software).
Homology searches and multiple sequence alignments (clustalw) were
carried out using the BLAST server of the National Center for
Biotechnology Information (http://www.ncbi.nlm.nih.gov) and the
software available on the Web page of the Poˆle-Bioinformatique
Lyonnais (http://pbil.univ-lyon1.fr/). The Neural Network Promoter
Prediction Software (http://www.fruitfly.org/seq_tools/) was used for
searching putative promoter regions. Homology trees were constructed
with the TreeTop-Phylogenetic Prediction program (http://www.
genebee.msu.su/).
Preparation of inside-out membrane vesicles. For the isolation
of inside-out membrane vesicles of L. lactis NZ9000, cells were grown
at 30 uC to an OD600 of about 0?4. At this point, 0?1% (v/v) of the
supernatant of the nisin-producing L. lactis strain NZ9700 was added
to the culture to trigger transcription of the abcA or abcB gene, or
jointly the abcA/abcB genes from the nisA promoter. Subsequently,
the cells were incubated for 1 h at 30 uC, harvested at an OD600 of
approximately 0?8 by centrifugation, and membrane vesicles were
obtained as previously described (Margolles et al., 1999). The mem-
brane vesicles were stored in small aliquots in liquid nitrogen.
Antimicrobial susceptibility testing. Cells were grown at 30 uC
to an OD600 of about 0?4 in GM17 broth containing chlorampheni-
col or erythromycin, or both. To induce gene expression at this
point, 0?1% (v/v) of the culture supernatant of L. lactis NZ9700 was
added to the GM17 broth. Subsequently, the cells were incubated
for 1 h. For MIC determinations, 1 ml of the culture was added to
30 ml soft (0?7% agar) GM17 at 40 uC, containing 0?1% of the L.
lactis NZ9700 culture supernatant. Then, the mixture was layered on
the top of 15 cm Petri dishes containing 50 ml GM17 (2% agar), to
which supernatant of the L. lactis nisin-producing strain had been
added. E-test strips of 15 different antibiotics were applied with an
applicator, and MICs were determined after 24 h incubation. For
resistance assays on agar media, cultures were centrifuged, resus-
pended in GM17 broth and the OD600 was adjusted to 1. Then,
serial 10-fold dilutions were performed, and 5 ml of each dilution
was spotted on the GM17 agar medium with or without the inhibi-
tory agent (nisin or polymyxin B). The plates were incubated for
24 h and all the experiments were done at least in triplicate.
Hoechst-33342 transport in membrane vesicles. Inside-out
membrane vesicles (1 mg of total membrane protein) were diluted
in 2 ml ATP regenerating buffer (50 mM potassium HEPES buffer,
pH 7?1, containing 5 mM MgSO4, 8?5 mM NaCl, 0?1 mg creatine
kinase ml21 and 5 mM phosphocreatine) in a 3 ml quartz cuvette.
After 1 min incubation at 30 uC, Hoechst-33342 was added to a final
concentration of 0?2 mM. Once the signal was stable, Mg2+-ATP or
Mg2+-AMP-PNP was added to a final concentration of 2 mM, and
the fluorescence intensity (excitation 355 nm, emission 457 nm) was
followed with an Eclipse fluorescence spectrophotometer (Varian)
provided with a magnetically stirred holder at 30 uC.
Affinity purification and identification of the purified pro-
teins. Inside-out membrane vesicles from L. lactis NZ9000 contain-
ing pNHAbcA/pNAbcB (12 mg total membrane protein ml21) were
solubilized in 50 mM potassium phosphate buffer, pH 8?0, contain-
ing 10% (v/v) glycerol, 100 mM NaCl and 1% (w/v) DDM. The
suspension was mixed and, after 30 min incubation at 4 uC, the
insoluble material was removed by centrifugation (250 000 g,
20 min, 4 uC). For purification of histidine-tagged AbcA, 1 ml solu-
bilized membrane proteins was mixed and incubated for 1 h with
200 ml Ni-NTA agarose, which was preequilibrated in buffer A
[50 mM potassium phosphate, pH 8?0, 100 mM NaCl, 10% (v/v)
glycerol, 0?05% (w/v) DDM] plus 10 mM imidazole. After incuba-
tion, the resin was transferred to a Bio-spin column (Bio-Rad) and
washed first with 25 column volumes of buffer A containing 10 mM
imidazole, and subsequently with 12 column volumes of buffer A
(pH 7?0) containing 30 mM imidazole. The protein was eluted with
buffer A, pH 7?0, supplemented with 250 mM imidazole. All steps
were carried out at 4 uC.
Proteins from the membrane and eluted fractions were checked by
SDS-PAGE by using a Mini-Protean II system (Bio-Rad). SDS-PAGE
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gels were stained with Coomassie BioSafe (Bio-Rad), and densito-
metric scanning was carried out by using the Gel Doc 2000 system with
the Quantity One software (Bio-Rad). For protein identification, bands
were excised from gels and submitted to tryptic digestion, and mass
spectrometry analyses were performed at the Servicio de Proteo´mica of
the Centro Nacional de Investigaciones Cardiovasculares. All protein
concentrations were determined by the Lowry method.
RESULTS AND DISCUSSION
Identification and sequence analysis of abcA
and abcB
A 7930 bp DNA fragment was selected from the preliminary
genome sequence of B. breve UCC2003 (S. Leahy, J. A.
Moreno, M. O’Connell-Motherway, H. G. Higgins, G. F.
Fitzgerald & D. Van Sinderen, unpublished data). Its genetic
analysis revealed the presence of two adjacent ORFs
displaying significant homology to several hypothetical
MDR transporters, named abcA and abcB, putatively
transcribed in the same direction and separated by
202 bp. A putative promoter sequence was found 182 bp
upstream of the potential abcA start codon, but not
upstream of the abcB gene. The first gene, abcA, possesses
a putative ribosome-binding site 8 bp upstream of its start
codon (GGTGAT), while the second gene, abcB, is followed
by a transcription terminator-like (inverted repeat)
sequence (Fig. 1a). The abcA and abcB genes are predicted
to encode 636 and 601 aa proteins, respectively, identified
by a database enquiry (BLASTP) as putative ABC transpor-
ters. Hydropathy profile analysis using the Expasy
Proteomic Server predicted that both proteins possess a
transmembrane domain, composed of six putative trans-
membrane helices, followed by a hydrophilic portion with a
putative ATP-binding domain, containing theWalker A and
Walker B motifs, and the ABC signature sequence
(Schneider & Hunke, 1998; Walker et al., 1982) (Fig. 1b).
Since the ABC domain is highly conserved, in order to
determine evolutionary relationships with other transpor-
ters the predicted permease domains of AbcA (339 N-
terminal amino acids) and AbcB (347 N-terminal amino
acids) were subjected to BLASTP analysis and compared with
homologous sequences. Analysis of a multiple alignment of
the primary sequence of these domains showed that they are
closely related to a number of ABC transporters from
bacteria (Fig. 1c, d). Both protein A and B domains
displayed the highest homology scores with proteins that
were located in tandem on the genomes. Interestingly, the
AbcA permease domain matched with proteins encoded by
the upstream genes, whereas the AbcB permease domain
matched with proteins encoded by the downstream genes of
the tandem-like structures. These results indicated that
AbcA/AbcB homologues are widely distributed in bacteria,
and most likely they are orthologous systems performing
similar physiological functions. This prompted us to study
the functionality of both proteins (independently or
together) by investigating phenotypic changes of a cell
that expresses these proteins, as well as determining their
role in multidrug resistance and their ability to transport
drugs.
Production of the ABC transporters and
antimicrobial activity profiles
In recent years, molecular techniques for disrupting genes
and controlling gene expression have been extensively used
to functionally study MDR transporters (Doerrler & Raetz,
2002; Hirata et al., 2004; Lubelski et al., 2004; Ravaud et al.,
2006). However, the lack of efficient transformation systems
and the paucity of effective molecular tools (e.g. cloning and
expression vectors and gene inactivation systems) have so
far severely limited functional studies in Bifidobacterium
(Ventura et al., 2004). Since previous studies from our
group have shown that the nisin-inducible system from
the Gram-positive bacterium L. lactis can generate large
quantities of bifidobacterial membrane and cytosolic
proteins (Margolles & de los Reyes-Gavila´n, 2003;
Margolles et al., 2005), we selected this bacterium as the
host to produce AbcA and AbcB. We cloned (independently
or together) abcA and abcB by constructing plasmids
pNAbcA and pNAbcB, which were then introduced into L.
lactis cells. Both plasmids could be maintained in the same
host cell after more than 70 generations. Total cell counts
indicated that all cells contained the two antibiotic markers,
and no recombinations or mutations were observed after
sequencing and restriction enzyme analysis of the plasmids
in any of the tested colonies. This proves that pNAbcA and
pNAbcB could co-exist and are stable in the same cell, and
shows that they did not segregate and were not maintained
in different cell subpopulations.
Gene expression and protein synthesis were investigated by
real-time PCR and SDS-PAGE. Only the expression of AbcB
was apparent on the protein electrophoresis profiles,
probably due to the coincidence of the molecular mass of
AbcA with one of the major membrane proteins of L. lactis
(Fig. 2). However, real-time PCR showed that both abcA
and abcB were transcribed, either when the genes were
cloned separately or together. Interestingly, in cells carrying
both pNAbcA and pNAbcB, the abcB transcript appears to
be about two times more abundant than the abcA transcript
(2DDCT=21?04±0?059), whereas when abcA and abcB were
expressed alone, their transcripts were 22?43±1?17 times and
21?49±1?52 times more abundant, respectively, than the
corresponding transcripts of the cells containing both
plasmids.
We investigated if AbcA and AbcB could be involved in
conferring antimicrobial resistance. We determined the
MIC of 15 antibiotics using E-test strips, a quantitative
method that has emerged in the last few years as an accurate
alternative to the traditional methods, such as microdilution
and disk diffusion (Turnbull et al., 2004). The antibiotics
tested were ampicillin, benzylpenicillin, clindamycin, cipro-
floxacin, doxycycline, kanamycin, meropenem, minocy-
cline, polymyxin, quinupristin-dalfopristin, rifampicin (low
range, 0?002 to 32 mg ml21), streptomycin (high range,
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0?064 to 1,024 mg ml21), tetracycline, trimethoprim-sulfa-
methoxazole, and vancomycin. Chloramphenicol and
macrolides were not tested since they are the selection
markers in the vectors. A small increase in resistance was
observed for ciprofloxacin. The MICs for the control strain,
harbouring the empty plasmid, and the strain harbouring
pNAbcA were 3?3±0?6 mg ml21, whereas those for cells
containing pNAbcB or pNAbcA/pNAbcB were 6?0±0 and
6?7±1?2 mg ml21, respectively. Interestingly, a recent
report demonstrated that the increased expression of two
multidrug ABC transporter-like genes is associated with
ethidium bromide and ciprofloxacin resistance in
Mycoplasma hominis (Raherison et al., 2005). In our case,
the most significant changes were found for polymyxin B,
Fig. 1. (a) Organization of the B. breve UCC2003 genomic region containing the abcA and abcB genes. The white arrows
indicate the relative positions and direction of transcription of the ORFs. The pin-like symbol indicates a terminator-like
sequence. Relevant restriction sites and their locations in the sequence are also indicated. A putative promoter region is
indicated with a black arrow upstream of abcA. (b) Modular structure of AbcA and AbcB. The amino acid sequences in
parentheses are the consensus sequences of the ABC transporter family. TMD, transmembrane domain; X, any amino acid; h,
hydrophobic residue. (c, d) Phylogenetic relationship analysis of the permease domains of AbcA (c) and AbcB (d). Database
accession numbers are given in parentheses. Trees were constructed with the matrix of pair distances between sequences
using the cluster algorithm, and bootstrap values (100 replicates) are given at the branch points.
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the resistance increasing more than fourfold for cells
expressing AbcA (MIC 42?7±9?2 mg ml21, compared to
9?3±2?3 for the control strain), and more than twelve-fold
for cells expressing AbcB (128?0±0 mg ml21) or both
proteins (149?3±40 mg ml21). No significant differences
between the control strain and the membrane-protein-
expressing cells were found for any other antibiotic using the
E-test assay.
Since polymyxin B is a polycationic antimicrobial peptide
that acts at the cell surface level, dissipating proton-motive
force by making pores in the cell membrane (Hancock &
Chapple, 1999), we decided to investigate the resistance-
conferring capability of AbcA and AbcB to the antimicrobial
peptide nisin. Therefore, susceptibility differences against
nisin and polymyxin B between L. lactis cells harbouring
pNAbcA, pNAbcB or pNAbcA/pNAbcB, and bacterial cells
harbouring the control plasmid, were determined in GM17
agar. The joint expression of AbcA and AbcB resulted in an
increased resistance to nisin and polymyxin with respect to
the control, which became apparent by colony formation at
the highest dilution used. However, considerable nisin
resistance was also found under similar conditions for cells
expressing only AbcB (Fig. 3). This indicated that the
expression of AbcB alone could also reduce the cell
susceptibility to nisin, although to a lesser extent than
when both proteins are co-expressed. Consistent with the
above finding, it has previously been shown that certain
ABC transporters can act on bacteriocin-like compounds.
For example, the ABC-transporter LmrB from L. lactis
confers resistance to LsbA and LsbB, two class II bacteriocins
(Gajic et al., 2003). It does so, most likely, by removing LsbA
and LsbB from the cytoplasmic membrane, which is the
target of these antimicrobial peptides. Other studies have
suggested that ABC transporters could play a key role in
generating resistance to nisin and other antimicrobial
peptides in Gram-positive bacteria (Kok et al., 2005).
Transport of Hoechst-33342 in membrane
vesicles
Hoechst-33342 is a cytotoxic drug extensively employed to
detect the activity of MDR transporters (Lubelski et al.,
2004; Margolles et al., 1999; Sakamoto et al., 2001; van Veen
et al., 2000; Woebking et al., 2005). This probe has the
property of being fluorescent when present in the lipid
environment of biomembranes, while being essentially non-
fluorescent in the aqueous phase (Shapiro & Ling, 1995).
Since MDR transporters are thought to pump out
hydrophobic drugs from (or close to) the cytoplasmic
membrane (Putman et al., 2000), this compound was used
to study the extrusion of drugs directly from the membrane
to the aqueous phase, via the decrease of fluorescence
observed when extrusion activity is present (Margolles et al.,
1999; Shapiro & Ling, 1995; Woebking et al., 2005).
Furthermore, the advantage of carrying out functional
Fig. 2. Expression of AbcA and AbcB and co-purification of
the AbcA/AbcB complex. Coomassie BioSafe-stained SDS-
PAGE gel of inside-out membrane vesicles (30 mg protein/lane)
from cells harbouring the empty vector (pNZ8048, lane 1) or
cells expressing AbcA (pNAbcA, lane 2), AbcB (pNAbcB, lane
3), or jointly AbcA and AbcB (pNAbcA/pNAbcB, lane 4). The
purified histidine-tagged AbcA from a Ni-NTA column with
250 mM imidazole and the co-eluted protein AbcB are repre-
sented in lane 5. MM, protein markers (molecular masses in
kDa are indicated on the right). The arrows indicate the posi-
tions of AbcA and AbcB.
Fig. 3. Effect of AbcA, AbcB, and AbcA/
AbcB expression on the susceptibility of L.
lactis to nisin and polymyxin. Results shown
are from cells harbouring pNZ8048 (1),
pNAbcA (2), pNAbcB (3), or pNAbcA and
pNAbcB (4) and spotted on GM17 plates
containing 78 ng nisin ml”1 or 62 mg poly-
myxin B ml”1.
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studies in isolated membranes is the avoidance of possible
interference caused by other cellular components that may
modify the transport activity. Experiments performed in
inside-out membrane vesicles of L. lactis NZ9000 cells
showed the highest transport rate of Hoechst-33342 in
membranes harbouring AbcA and AbcB, although signifi-
cant transport was also detected in AbcB-containing
membrane vesicles. AbcA-containing membranes displayed
an extremely low transport activity as compared to the other
two membrane systems (Fig. 4). In addition, the ATP-
dependency of the transport process was demonstrated,
since no activity was detected in the presence of the non-
hydrolysable ATP analogue AMP-PNP. ATP-dependent
transport of Hoechst-33342 was not observed in control
membrane vesicles.
AbcA and AbcB form a stable complex in the
membrane
The results of the experiments described above point to
cooperation between AbcA and AbcB that results in an
increased resistance to nisin and polymyxin, and an
enhanced ability to extrude Hoechst-33342 from the
membrane of L. lactis. As suggested for other ABC
transporters (Abele & Tampe, 1999; Lee et al., 2003;
Lubelski et al., 2004), this is likely to happen through a direct
interaction of AbcA and AbcB in themembrane, where these
two proteins are assumed to form a complex that represents
the functional unit of the transporter. To prove this
assumption for the AbcAB proteins, a histidine tag was
attached to the C-terminal part of AbcA to facilitate
purification of the complex by affinity chromatography. For
this purpose, membranes were isolated from cells harbour-
ing pNHAbcA/pNAbcB, solubilized with a DDM-contain-
ing buffer and subjected to a single-step Ni-NTA affinity
purification procedure (Fig. 2). When His-tagged AbcA was
purified, two protein bands were eluted, with molecular
masses that correspond to AbcA and AbcB. The identity of
the proteins was confirmed by mass spectrometry, the upper
band being identified as AbcA, and the lower as AbcB.
Purified proteins were analysed by densitometry of
Coomassie BioSafe-stained SDS-PAGE gels, showing that
both proteins are present in approximately equal amounts,
indicating the existence of a stable membrane-associated
complex with a stoichiometry of 1 : 1 (Fig. 2).
It has been experimentally proved that several prokaryotic
ABC transporters act as dimers. Homodimerization has
been demonstrated for LmrA of L. lactis (van Veen et al.,
2000), MsbA of E. coli (Chang & Roth, 2001) and BmrA of B.
subtilis (Ravaud et al., 2006), while a heterodimeric complex
was found to be the functional unit of the MDR transporter
LmrCD from L. lactis (Lubelski et al., 2004). However, in
our study we have found that AbcB can retain some activity
by itself, conferring nisin resistance and extruding Hoechst-
33342 from the membrane, although to a lesser extent than
when both proteins are present. A similar effect has also been
reported for other ABC transporters. In eukaryotic cells, the
mammalian proteins ADLP (adrenoleukodystrophy pro-
tein), ALDRP (adrenoleukodystrophy-related protein) and
PMP70 (70 kDa peroxisomal protein) were found to act as
homo- as well as heterodimers, and it was proposed that the
different dimer combinations vary in activity and substrate
specificity (Liu et al., 1999). Genetic evidence suggests that
the substrate specificity of the traffic ATPase transporters
involved in the uptake of eye pigment precursors in
Drosophila melanogaster (the white, scarlet and brown
gene products) depends on the dimer formed: white and
scarlet together form a tryptophan transporter, while the
white and brown gene products form a guanine transporter
100
200 400 600 800 200 400 600 800 200 400 600 800
80
60F
lu
or
es
ce
nc
e 
(%
)
(a) (b) (c)
Time (s)
Fig. 4. AbcA-, AbcB- and AbcA/AbcB-mediated extrusion of Hoechst-33342 from inside-out membrane vesicles.
Membranes were prepared from NZ9000 cells harbouring pNAbcA (a); pNAbcB (b), or pNAbcA/pNAbcB (c). The arrow
indicates the addition of 2 mM ATP (black lines) or AMP-PNP (grey lines). Hoechst-33342 transport in L. lactis NZ9000/
pNZ8048 control membranes was not observed under the same assay conditions (data not shown). The graphics shown are
representative of three independent experiments with three different batches of vesicles for each strain.
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(Mackenzie et al., 1999). In a similar way, we have observed
that when AbcA and AbcB are co-expressed in L. lactis cells,
AbcB is produced about two times more than AbcA. This
implies that in pNAbcA/pNAbcB-containing cells there
would be a population of free AbcB, not bound to AbcA.
Since we have shown that AbcB alone is active under certain
conditions, this could partially mask the activity of the
heterodimer. Future reconstitution studies could address
these questions.
In short, this study has provided evidence that AbcA and
AbcB act as a heterodimeric ABC-type multidrug transpor-
ter, conferring resistance to nisin and polymyxin and
extruding cytotoxic compounds. Therefore, we propose to
rename AbcA and AbcB as BbmA (Bifidobacterium breve
multidrug transporter) and BbmB, respectively. These
findings provide the basis for further biochemical studies
of BbmAB and the half-size transporters BbmA and BbmB,
and open some questions about the physiological role of this
B. breve transporter in its natural environment, the intestinal
niche.
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